Efficacy and Safety of Ixekizumab with or Without Methotrexate in Biologic-Naïve Patients with Psoriatic Arthritis: 52-Week Results from SPIRIT-H2H Study
posted on 2020-11-10, 17:00authored byJosef S. Smolen, Anthony Sebba, Eric M. Ruderman, Hendrik Schulze-Koops, Christophe Sapin, Amanda M. Gellett, Aubrey Trevelin Sprabery, Lingnan Li, Inmaculada de la Torre, Gaia Gallo, Soyi Liu-Leage, Sreekumar Pillai, Paulo Reis, Peter Nash
Article full
text
The above Summary Slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).